(Q38576860)

4 September 2017

title

A personal history of the CAMPATH-1H antibody (English)

1 reference

4 September 2017

1

Herman Waldmann

1 reference

4 September 2017

publication date

1 January 2002

1 reference

4 September 2017

1 reference

4 September 2017

volume

19 Suppl

1 reference

4 September 2017

page(s)

S3-9

1 reference

https://scigraph.springernature.com/pub.10.1385/mo:19:2s:s03

4 September 2017

exact match

0 references

cites work

In vivo 'Purging' of residual disease in CLL with Campath-1H

1 reference

12 December 2020

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies

1 reference

12 December 2020

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

1 reference

12 December 2020

THERAPEUTIC POTENTIAL OF MONOCLONAL ANTIBODIES TO THE LEUKOCYTE-COMMON ANTIGEN

1 reference

12 December 2020

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

12 December 2020

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection

1 reference

12 December 2020

Collection and cryopreservation of human stem and progenitor cells for bone marrow transplantation

1 reference

12 December 2020

Humanized monoclonal antibody treatment in rheumatoid arthritis

1 reference

12 December 2020

Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?

1 reference

12 December 2020

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype

1 reference

12 December 2020

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

12 December 2020

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation

1 reference

12 December 2020

Isolation of low-frequency class-switch variants from rat hybrid myelomás

1 reference

12 December 2020

A rapid solid-phase enzyme-linked binding assay for screening monoclonal antibodies to cell surface antigens

1 reference

12 December 2020

New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation.

1 reference

12 December 2020

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation

1 reference

12 December 2020

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

1 reference

12 December 2020

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

1 reference

12 December 2020

CAMPATH-1H in inflammatory arthritis

1 reference

12 December 2020

Immunosuppression with monoclonal antibodies. A model to determine the rules for effective serotherapy

1 reference

12 December 2020

Reshaping human antibodies for therapy

1 reference

12 December 2020

Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes

1 reference

12 December 2020

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy

1 reference

12 December 2020

Identifiers

DOI

10.1385/MO:19:2S:S03

1 reference

Dimensions Publication ID

4 September 2017

1040387639

0 references

1 reference